China Universal Asset Management Co., Ltd. Dice Therapeutics, Inc. Transaction History

China Universal Asset Management Co., Ltd.

$893 Million
Q3 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 May 21, 2024	SELL	$25.86 - $46.71 $517 - $934	-20 Reduced 3.1%	626 $29,000
Q2 2023 Jul 27, 2023	SELL	$25.86 - $46.71 $517 - $934	-20 Reduced 3.1%	626 $29,000
Q1 2023 May 21, 2024	BUY	$26.05 - $32.31 $4,220 - $5,234	162 Added 33.47%	646 $18,000
Q1 2023 Apr 27, 2023	BUY	$26.05 - $32.31 $4,220 - $5,234	162 Added 33.47%	646 $19,000
Q4 2022 May 21, 2024	BUY	$19.77 - $42.23 $9,568 - $20,439	484 New	484 $15,000
Q4 2022 Jan 31, 2023	BUY	$19.77 - $42.23 $9,568 - $20,439	484 New	484 $15,000

Others Institutions Holding DICE

# of Institutions

Shares Held

17.7K

Call Options Held

13K

Put Options Held

View Full List

About DICE Therapeutics, Inc.

Ticker DICE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,430,000
Description
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...

More about DICE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.

Account